Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,679 | 179 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $363.83 | 28 | $0 (2022) |
| PFIZER INC. | $203.88 | 12 | $0 (2019) |
| Novo Nordisk Inc | $203.39 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $185.82 | 10 | $0 (2021) |
| Astellas Pharma US Inc | $179.21 | 14 | $0 (2021) |
| ABBVIE INC. | $165.07 | 11 | $0 (2023) |
| Allergan, Inc. | $164.59 | 17 | $0 (2020) |
| Lilly USA, LLC | $158.65 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $153.05 | 9 | $0 (2024) |
| Amgen Inc. | $137.23 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.66 | 10 | Amgen Inc. ($34.82) |
| 2023 | $177.82 | 9 | ABBVIE INC. ($54.65) |
| 2022 | $250.46 | 13 | Lilly USA, LLC ($64.79) |
| 2021 | $429.69 | 30 | AbbVie Inc. ($110.42) |
| 2020 | $86.64 | 6 | Novo Nordisk Inc ($25.36) |
| 2019 | $497.13 | 32 | Janssen Pharmaceuticals, Inc ($84.52) |
| 2018 | $488.62 | 36 | Janssen Pharmaceuticals, Inc ($144.35) |
| 2017 | $581.61 | 43 | Allergan Inc. ($122.42) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Inflammation | ||||||
| 02/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Inflammation | ||||||
| 10/06/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: VACCINES | ||||||
| 08/29/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Diabetes | ||||||
| 04/26/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 04/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: RESPIRATORY | ||||||
| 03/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 03/16/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Diabetes Care | ||||||
| 03/03/2023 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: IMMUNOLOGY | ||||||
| 03/02/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Diabetes | ||||||
| 12/02/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: INSOMNIA | ||||||
| 09/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 09/08/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 07/27/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 704 | 1,377 | $88,863 | $43,900 |
| 2022 | 16 | 699 | 1,372 | $80,950 | $38,239 |
| 2021 | 17 | 728 | 1,383 | $90,321 | $44,390 |
| 2020 | 16 | 899 | 3,580 | $305,643 | $151,261 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 197 | $29,550 | $13,937 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 255 | $26,010 | $12,663 | 48.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $5,540 | $4,650 | 83.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 34 | $6,460 | $3,686 | 57.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 13 | $3,510 | $2,620 | 74.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 63 | 154 | $6,160 | $1,151 | 18.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 19 | 22 | $990.00 | $892.10 | 90.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 27 | $1,620 | $810.27 | 50.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 20 | 46 | $1,426 | $746.12 | 52.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 22 | $1,606 | $719.08 | 44.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 33 | 35 | $2,688 | $695.93 | 25.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 87 | 110 | $660.00 | $646.80 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 30 | $450.00 | $285.60 | 63.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 54 | 336 | $1,680 | $202.86 | 12.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 46 | 57 | $513.00 | $194.37 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 163 | $24,450 | $11,563 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 228 | $23,304 | $11,470 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $4,630 | $4,080 | 88.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 33 | $6,270 | $3,206 | 51.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 66 | 173 | $6,840 | $1,496 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,552 | $1,267 | 49.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 21 | 26 | $1,898 | $1,014 | 53.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 22 | 24 | $1,080 | $984.41 | 91.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $1,950 | $848.82 | 43.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 26 | 36 | $2,772 | $746.69 | 26.9% |
About Dr. Michael Remillard, M.D
Dr. Michael Remillard, M.D is a Family Medicine healthcare provider based in Helena, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255444089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Remillard, M.D has received a total of $2,679 in payments from pharmaceutical and medical device companies, with $166.66 received in 2024. These payments were reported across 179 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,679).
As a Medicare-enrolled provider, Remillard has provided services to 3,030 Medicare beneficiaries, totaling 7,712 services with total Medicare billing of $277,790. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Helena, AL
- Active Since 08/16/2006
- Last Updated 10/06/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255444089
Products in Payments
- XARELTO (Drug) $348.54
- ENTRESTO (Drug) $185.82
- TRELEGY ELLIPTA (Drug) $123.21
- MYRBETRIQ (Drug) $117.77
- MOUNJARO (Drug) $117.02
- CHANTIX (Drug) $116.78
- Ozempic (Drug) $103.85
- UBRELVY (Drug) $101.55
- MYDAYIS (Drug) $94.67
- LYRICA (Drug) $87.10
- Aimovig (Biological) $85.57
- Rybelsus (Drug) $82.67
- LINZESS (Drug) $71.80
- ADUHELM (Biological) $70.39
- VYVANSE (Drug) $46.64
- NUPLAZID (Drug) $46.40
- Trulance (Drug) $42.67
- VIBERZI (Drug) $42.59
- FREESTYLE LIBRE 2 (Device) $37.25
- Myrbetriq (Drug) $36.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Helena
Mr. Robert Johnson, D.o, D.O
Family Medicine — Payments: $3,014
Dr. Christopher Holdhusen, M.d, M.D
Family Medicine — Payments: $994.62
Dr. Sheri Howell, Md, MD
Family Medicine — Payments: $922.80
Dr. L.j. Bell, D.o, D.O
Family Medicine — Payments: $874.26
Dr. William Batey, M.d, M.D
Family Medicine — Payments: $654.27
Tatiana Sanchez, Md, MD
Family Medicine — Payments: $601.25